A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis

NCT03165435 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Not enough participating centres to complete recruitment in a timely manner.

Conditions

Interventions

Sponsor

CuraVac

Collaborators